Yüklüyor......
Atezolizumab for the treatment of non-small cell lung cancer
INTRODUCTION: The immune system can restrain or promote cancer development and growth. Antibodies targeting immune checkpoints have revolutionized cancer treatment. Among the best responses have been in non-small cell lung cancer (NSCLC) which is largely caused by chronic exposure to carcinogens; as...
Kaydedildi:
| Yayımlandı: | Expert Rev Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089509/ https://ncbi.nlm.nih.gov/pubmed/28714780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1356717 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|